EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring the anti-obesity effects of Lactobacillus in C57BL/6 mice: mechanisms, interventions, and future directions

Sharoen Yu Ming Lim iD, E-Jayn Chong, Weng Yan Mah, Yan Pan iD, Chee Mun Fang iD, Chandrika Murugaiah, Mustafa Alshagga iD

Letters in Applied Microbiology · 03.03.2025 · 78 (3)

DOI: 10.1093/lambio/ovaf024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Letters in Applied Microbiology, online erschienen am 18.02.2025. Verfasst von Sharoen Yu Ming Lim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biomedical Sciences, School of Pharmacy, University of Nottingham Malaysia, 43500 Semenyih, Selangor, Malaysia. Hauptthemen laut MEDLINE: Obesity, Probiotics, Lactobacillus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lactobacillus species show strong potential in fighting obesity-related inflammation and metabolic issues. Obesity causes inflammation in adipose tissue, which harms insulin sensitivity and leads to fat buildup. Lactobacillus strains like Lactobacillus gasseri, Lactobacillus reuteri, and Lactobacillus plantarum help regulate lipid metabolism by boosting key genes, preventing fat cell formation, and encouraging fat breakdown. They also produce short-chain fatty acids (SCFAs) that improve gut health, activate metabolic pathways, and reduce inflammation. Studies in animals have shown that Lactobacillus can reduce body weight, fat, and inflammation, with Lactobacillus plantarum being especially effective in improving gut microbiota and liver function. When combined with other probiotics or prebiotics, these strains work even better, enhancing lipid metabolism and reducing inflammation. These results suggest that Lactobacillus could be an effective way to manage obesity and related health problems by influencing metabolism, gut health, and inflammation. However, more research, particularly human clinical trials, is needed to confirm its potential as a dietary treatment for obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityProbioticsLactobacillusAnimalsMice, Inbred C57BLGastrointestinal MicrobiomeMiceHumansLipid MetabolismInflammation

Stichwörter der Autor:innen

C57BL/6HFD-induced obesityLactilactobacillusLatilactobacillusobese mice

Autor:innen und Institutionen

  • Division of Biomedical Sciences, School of Pharmacy, University of Nottingham Malaysia, 43500 Semenyih, Selangor, Malaysia.
  • Faculty of Business, Design and Arts, Swinburne University of Technology, 93350 Kuching, Sarawak, Malaysia.
  • Faculty of Medicine, Manipal University College Malaysia, Bukit Baru 75150 Melaka, Malaysia.

ORCID-Profile: Sharoen Yu Ming Lim, Yan Pan, Chee Mun Fang, Mustafa Alshagga

Zitieren

APA

Lim, S. Y. M., Chong, E. J., Mah, W. Y., Pan, Y., Fang, C. M., Murugaiah, C., & Alshagga, M. (2025). Exploring the anti-obesity effects of Lactobacillus in C57BL/6 mice: mechanisms, interventions, and future directions. Letters in Applied Microbiology, 78(3). https://doi.org/10.1093/lambio/ovaf024

Vancouver

Lim SYM, Chong EJ, Mah WY, Pan Y, Fang CM, Murugaiah C, et al. Exploring the anti-obesity effects of Lactobacillus in C57BL/6 mice: mechanisms, interventions, and future directions. Letters in Applied Microbiology. 2025;78(3). doi:10.1093/lambio/ovaf024

BibTeX
@article{Lim2025,
  author = {Lim, Sharoen Yu Ming and Chong, E-Jayn and Mah, Weng Yan and Pan, Yan and Fang, Chee Mun and Murugaiah, Chandrika and Alshagga, Mustafa},
  title = {Exploring the anti-obesity effects of Lactobacillus in C57BL/6 mice: mechanisms, interventions, and future directions},
  journal = {Letters in Applied Microbiology},
  year = {2025},
  volume = {78},
  number = {3},
  doi = {10.1093/lambio/ovaf024}
}
Kostenlos starten →